<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01506258</url>
  </required_header>
  <id_info>
    <org_study_id>HE-11-011</org_study_id>
    <nct_id>NCT01506258</nct_id>
  </id_info>
  <brief_title>Autologous Stem Cells in Newborns With Oxygen Deprivation</brief_title>
  <official_title>Effects of the Infusion of Autologous Non-cryopreserved CD34+ Cells in Newborns With Asphyxia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Dr. Jose E. Gonzalez</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the plasticity of autologous intravenous
      application of cord blood stem cells would improve the clinical course of asphyxiated
      newborns.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When there is oxygen deprivation, more frequently in premature newborns, the brain and other
      organs suffer severe consequences. There is evidence that hematopoietic stem cells can help
      in this scenario by promoting the release of growth-enhancing factors that can help control
      the damage due to their &quot;homing&quot; capacity, which attracts them to injured sites.

      Cord and placental blood have a high concentration of these stem cells, and because its
      obtention is relatively easy, it seems like a feasible treatment in perinatal hypoxia.

      There are current clinical trials that use cryopreserved cord blood for these patients but,
      to do that, the stem cells have to be frozen and then thawed to be infused, losing a
      considerable amount of stem cells (almost half of them). We want to evaluate the same
      condition but infusing non-cryopreserved autologous cord and placental blood because we
      believe it can be more beneficial due to the greater amount of cells infused, the avoidance
      of the cryoprotection agent´s toxicity and the lower costs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">April 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of Stem Cell Infusion at 1 week after discharge</measure>
    <time_frame>1 week</time_frame>
    <description>Clinical assessment, including the Amiel-Tison Neurological Assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of Stem Cell Infusion at 1 year after discharge</measure>
    <time_frame>1 year</time_frame>
    <description>Clinical assessment, including the Amiel-Tison Neurological Assessment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Apgar; 0-3 at 1 Minute</condition>
  <condition>Metabolic Acidosis</condition>
  <condition>Hypoxia, Brain</condition>
  <condition>Multiple Organ Failure</condition>
  <arm_group>
    <arm_group_label>Patients not infused with stem cells</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Historic Controls</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients infused with stem cells</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Application of Stem Cells</intervention_name>
    <description>IV infusion of autologous stem cells within the first 48 hours after birth.</description>
    <arm_group_label>Patients infused with stem cells</arm_group_label>
    <other_name>IV infusion of autologous cord and placental cord blood</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Control group of patients that meet the inclusion criteria but that do not wish to have the intervention.</description>
    <arm_group_label>Patients not infused with stem cells</arm_group_label>
    <other_name>Comparison group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Apgar &lt; 5 at 5 minutes

          -  Mixed or metabolic acidosis with a pH &lt;7.0 from umbilical cord blood sample

          -  Neurological manifestations compatible with Hypoxic-Ischemic Encephalopathy

          -  Any degree of organic/systemic affectation (cardiovascular, gastrointestinal,
             hematologic and/or respiratory)

        Exclusion Criteria:

          -  Neurodegenerative, autoimmune or genetic disease

          -  Active infection at birth

          -  Informed Consent not signed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>37 Weeks</minimum_age>
    <maximum_age>42 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Consuelo Mancias-Guerra, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Dr. Jose E. Gonzalez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alma R Marroquin-Escamilla, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario Dr. Jose E. Gonzalez</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Gómez-Almaguer, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Universitario Dr. Jose E. Gonzalez</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Consuelo Mancias-Guerra, MD</last_name>
    <phone>+52 81 83 48 61 36</phone>
    <phone_ext>413</phone_ext>
    <email>consuelo@mancias.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alma R Marroquin-Escamilla, MD</last_name>
    <phone>+52 81 83 48 61 36</phone>
    <email>arme25@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neonatology Department of the Pediatrics Service, Hospital Universitario Dr. Jose E. Gonzalez</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Consuelo Mancias-Guerra, MD</last_name>
      <phone>+52 01 86 75 67 18</phone>
      <email>consuelo@mancias.com</email>
    </contact>
    <investigator>
      <last_name>Alma R Marroquin-Escamilla, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Cecilia Sosa-Cortez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sagrario L Valdes-Burnes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Barbara G Cardenas-del Castillo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriana Nieto-Sanjuanero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oscar Gonzalez-Llano, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Villarreal-Martinez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura M Nuño-Vazquez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josue E Rios-Solis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2012</study_first_submitted>
  <study_first_submitted_qc>January 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 9, 2012</study_first_posted>
  <last_update_submitted>January 18, 2012</last_update_submitted>
  <last_update_submitted_qc>January 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Dr. Jose E. Gonzalez</investigator_affiliation>
    <investigator_full_name>Consuelo Mancias Guerra</investigator_full_name>
    <investigator_title>Pediatric Hematology Professor</investigator_title>
  </responsible_party>
  <keyword>CD34+</keyword>
  <keyword>perinatal hypoxia</keyword>
  <keyword>autologous hematopoietic stem cells</keyword>
  <keyword>cord and placental blood</keyword>
  <keyword>cerebral palsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Acidosis</mesh_term>
    <mesh_term>Multiple Organ Failure</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

